Search

Research

Cardio-oncology is a new multidisciplinary area of expertise that seeks to pre-emptively and proactively address cardiac complications that emerge during and following cancer therapy. Modern therapies including molecular targeted therapy and immunotherapy have broadened the agents that can cause cardiac sequelae, often with complications arising within days to weeks of therapy.

Research

We provide evidence that targeting leukemia-induced bone loss is a therapeutic strategy for pre-B ALL

Research

We conclude that the novel chocolate-based formulation of midazolam provides improved tolerability while remaining efficacious

Research

Connective tissue growth factor (CTGF/CCN2) has long been associated with human cancers. The role it plays in these neoplasms is diverse and tumour specific.

Research

Although neurocognitive, psychological and behavioural problems were noted for some patients during medical review, only 20% of patients were formally assessed.

Research

Glucocorticoids (GCs) are among the most important drugs for the treatment of acute lymphoblastic leukaemia (ALL).

Research

Investigation of this rare mixed lineage leukemia cytogenetic abnormality aims to provide further evidence of the genetic changes that underpin this leukemia.

Research

The cure rate for pediatric patients with B precursor acute lymphoblastic leukemia (pre-B ALL) is steadily improving, however relapses do occur despite...

Research

Acute lymphoblastic leukemia (ALL) is the commonest childhood malignancy in Australian children

Research

Human embryonic stem cell-derived neural stem cells (hESC-NSCs) are an attractive cell type for studying